Literature DB >> 16570324

Yeast prion-protein, sup35, fibril formation proceeds by addition and substraction of oligomers.

Saravanakumar Narayanan1, Stefan Walter, Bernd Reif.   

Abstract

In analogy to human prions, a domain of the translation-termination protein in Saccharomyces cerevisiae, Sup35, can switch its conformation from a soluble functional state, [psi-], to a conformation, [PSI+], that facilitates aggregation and impairs its native function. Overexpression of the molecular chaperone Hsp104 abolishes the [PSI+] phenotype and restores the normal function of Sup35. We have recently shown that Hsp104 interacts preferably with low oligomeric species of a Sup35 derived peptide, Sup35[5-26]; however, due to possible exchange between different oligomeric states, it was not possible to obtain information on the distribution and stability of the oligomeric state. We show here, that low-molecular-weight oligomers (Sup35[5-26])n (n approximately = 4-6) are indeed important for the fibril formation and disassembly process. We find that Hsp104 is able to disaggregate Sup35[5-26] fibrils by substraction of hexameric to decameric Sup35[5-26] oligomers. This disaggregation effect does not require assistance from other chaperones and is independent of ATP at high Hsp104 concentrations. Furthermore, we demonstrate that critical oligomers have a preference for alpha-helical conformations. The conformational reorganization into beta-sheet structures seems to occur only upon incorporation of these oligomers into fibrillar structures. The results are demonstrated by using an equilibrium dialysis experiment that employed different molecular-weight cut-off membranes. A combination of thioflavin-T (ThT) fluorescence and UV measurements allowed the quantification of fibril formation and the amount of peptide diffusing out of the dialysis bag. CD and NMR spectroscopy data were combined to obtain structural information.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570324     DOI: 10.1002/cbic.200500382

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  19 in total

1.  Mechanistic Insights into Hsp104 Potentiation.

Authors:  Mariana P Torrente; Edward Chuang; Megan M Noll; Meredith E Jackrel; Michelle S Go; James Shorter
Journal:  J Biol Chem       Date:  2016-01-08       Impact factor: 5.157

2.  Essential role of coiled coils for aggregation and activity of Q/N-rich prions and PolyQ proteins.

Authors:  Ferdinando Fiumara; Luana Fioriti; Eric R Kandel; Wayne A Hendrickson
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

3.  Purification of hsp104, a protein disaggregase.

Authors:  Elizabeth A Sweeny; Morgan E DeSantis; James Shorter
Journal:  J Vis Exp       Date:  2011-09-30       Impact factor: 1.355

4.  Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities.

Authors:  James Shorter; Susan Lindquist
Journal:  Mol Cell       Date:  2006-08-04       Impact factor: 17.970

5.  Effect of electrostatics on aggregation of prion protein Sup35 peptide.

Authors:  Alexander M Portillo; Alexey V Krasnoslobodtsev; Yuri L Lyubchenko
Journal:  J Phys Condens Matter       Date:  2012-03-30       Impact factor: 2.333

Review 6.  The elusive middle domain of Hsp104 and ClpB: location and function.

Authors:  Morgan E Desantis; James Shorter
Journal:  Biochim Biophys Acta       Date:  2011-07-24

7.  The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils.

Authors:  V N Sivanandam; Murali Jayaraman; Cody L Hoop; Ravindra Kodali; Ronald Wetzel; Patrick C A van der Wel
Journal:  J Am Chem Soc       Date:  2011-03-07       Impact factor: 15.419

8.  Variant-specific [PSI+] infection is transmitted by Sup35 polymers within [PSI+] aggregates with heterogeneous protein composition.

Authors:  Sviatoslav N Bagriantsev; Elena O Gracheva; Janet E Richmond; Susan W Liebman
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

9.  Hsp104 antagonizes alpha-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease.

Authors:  Christophe Lo Bianco; James Shorter; Etienne Régulier; Hilal Lashuel; Takeshi Iwatsubo; Susan Lindquist; Patrick Aebischer
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 10.  Prion dynamics and the quest for the genetic determinant in protein-only inheritance.

Authors:  Suzanne S Sindi; Tricia R Serio
Journal:  Curr Opin Microbiol       Date:  2009-10-26       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.